There Is A Quest For Clarity Surrounding Editas Medicine Inc (NASDAQ: EDIT) Volatility

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Editas Medicine Inc is $403.80M. A total of 1.28 million shares were traded on the day, compared to an average of 2.12M shares.

In the most recent transaction, O’Neill Gilmore Neil sold 12,191 shares of EDIT for 5.50 per share on Jun 04 ’24. After the transaction, the CEO now owns 315,279 company shares. In a previous transaction on Jun 04 ’24, Mei Baisong sold 511 shares at 5.50 per share. EDIT shares that EVP, CHIEF MEDICAL OFFICER owns now total 141,032.

Among the insiders who sold shares, Lucera Erick disposed of 22,337 shares on May 20 ’24 at a per-share price of $5.61. This resulted in the EVP, CHIEF FINANCIAL OFFICER holding 116,829 shares of EDIT after the transaction. In another insider transaction, Hopfield Jessica bought 45,000 shares at $5.64 per share on May 13 ’24. Company shares held by the Director now total 67,700.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, EDIT has a high of $11.69 and a low of $4.45.

As of this writing, EDIT has an earnings estimate of -$0.7 per share for the current quarter. EPS was calculated based on a consensus of 17.0 estimates, with a high estimate of -$0.46 per share and a lower estimate of -$0.84. The company reported an EPS of -$0.56 in the last quarter

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EDIT’s latest balance sheet shows that the firm has $499.85M in Cash & Short Term Investments as of fiscal 2021. There were $26.38M in debt and $46.88M in liabilities at the time. Its Book Value Per Share was $3.58, while its Total Shareholder’s Equity was $553.64M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EDIT is Buy with a score of 3.88.

Most Popular

Related Posts